Australia markets closed

MacroGenics, Inc. (MGNX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.5900-0.0900 (-1.92%)
As of 09:43AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 293.12M
Enterprise value 142.90M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.95
Price/book (mrq)2.76
Enterprise value/revenue 3.42
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.00
52-week change 3-23.53%
S&P500 52-week change 323.23%
52-week high 321.8800
52-week low 33.1400
50-day moving average 310.5981
200-day moving average 310.1983

Share statistics

Avg vol (3-month) 32.47M
Avg vol (10-day) 31.67M
Shares outstanding 562.63M
Implied shares outstanding 662.63M
Float 851.56M
% held by insiders 12.65%
% held by institutions 1113.22%
Shares short (15 May 2024) 48.89M
Short ratio (15 May 2024) 42.44
Short % of float (15 May 2024) 417.42%
Short % of shares outstanding (15 May 2024) 414.19%
Shares short (prior month 15 Apr 2024) 48.6M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -53.60%
Operating margin (ttm)-590.40%

Management effectiveness

Return on assets (ttm)-38.77%
Return on equity (ttm)-21.58%

Income statement

Revenue (ttm)43.36M
Revenue per share (ttm)0.70
Quarterly revenue growth (yoy)-62.80%
Gross profit (ttm)N/A
EBITDA -175.06M
Net income avi to common (ttm)-23.24M
Diluted EPS (ttm)-0.3800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)184.24M
Total cash per share (mrq)2.94
Total debt (mrq)34.01M
Total debt/equity (mrq)32.04%
Current ratio (mrq)3.63
Book value per share (mrq)1.70

Cash flow statement

Operating cash flow (ttm)-111.02M
Levered free cash flow (ttm)-51.76M